These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17900571)

  • 61. Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Wang X; Hickey RJ; Malkas LH; Koch MO; Li L; Zhang S; Sandusky GE; Grignon DJ; Eble JN; Cheng L
    Prostate; 2011 May; 71(7):748-54. PubMed ID: 21031434
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proliferating cell nuclear antigen: a proteomics view.
    Naryzhny SN
    Cell Mol Life Sci; 2008 Nov; 65(23):3789-808. PubMed ID: 18726183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy.
    Kwan A; Mcdermott-Brown I; Muthana M
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205238
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Towards a High-Affinity Peptidomimetic Targeting Proliferating Cell Nuclear Antigen from
    Vandborg BC; Horsfall AJ; Pederick JL; Abell AD; Bruning JB
    J Fungi (Basel); 2023 Nov; 9(11):. PubMed ID: 37998903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin.
    Li CQ; Liu ZQ; Liu SS; Zhang GT; Jiang L; Chen C; Luo DQ
    Front Pharmacol; 2022; 13():822023. PubMed ID: 35401213
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A cell permeable bimane-constrained PCNA-interacting peptide.
    Horsfall AJ; Vandborg BA; Kikhtyak Z; Scanlon DB; Tilley WD; Hickey TE; Bruning JB; Abell AD
    RSC Chem Biol; 2021 Oct; 2(5):1499-1508. PubMed ID: 34704055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The γ-tubulin meshwork assists in the recruitment of PCNA to chromatin in mammalian cells.
    Corvaisier M; Zhou J; Malycheva D; Cornella N; Chioureas D; Gustafsson NMS; Rosselló CA; Ayora S; Li T; Ekström-Holka K; Jirström K; Lindström L; Alvarado-Kristensson M
    Commun Biol; 2021 Jun; 4(1):767. PubMed ID: 34158617
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential therapeutic targets shared between leishmaniasis and cancer.
    Rashidi S; Fernández-Rubio C; Manzano-Román R; Mansouri R; Shafiei R; Ali-Hassanzadeh M; Barazesh A; Karimazar M; Hatam G; Nguewa P
    Parasitology; 2021 May; 148(6):655-671. PubMed ID: 33536086
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication.
    Mansilla SF; de la Vega MB; Calzetta NL; Siri SO; Gottifredi V
    Genes (Basel); 2020 May; 11(6):. PubMed ID: 32481484
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Maneuvers on PCNA Rings during DNA Replication and Repair.
    Slade D
    Genes (Basel); 2018 Aug; 9(8):. PubMed ID: 30126151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes.
    Zins K; Heller G; Mayerhofer M; Schreiber M; Abraham D
    Oncotarget; 2018 May; 9(33):23126-23148. PubMed ID: 29796177
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Towards the Full Realization of 2DE Power.
    Naryzhny S
    Proteomes; 2016 Nov; 4(4):. PubMed ID: 28248243
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A proteomic analysis of acute leukemia cells treated with 9-hydroxyoctadecadienoic acid.
    Li Z; Chen B; Wang P; Li X; Cai G; Wei W; Dong W
    Lipids Health Dis; 2016 Nov; 15(1):192. PubMed ID: 27832777
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PCNA appears in two populations of slow and fast diffusion with a constant ratio throughout S-phase in replicating mammalian cells.
    Zessin PJ; Sporbert A; Heilemann M
    Sci Rep; 2016 Jan; 6():18779. PubMed ID: 26758689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The chemopreventive potential of Curcuma purpurascens rhizome in reducing azoxymethane-induced aberrant crypt foci in rats.
    Rouhollahi E; Moghadamtousi SZ; Al-Henhena N; Kunasegaran T; Hasanpourghadi M; Looi CY; Abd Malek SN; Awang K; Abdulla MA; Mohamed Z
    Drug Des Devel Ther; 2015; 9():3911-22. PubMed ID: 26251570
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach.
    Zorofchian Moghadamtousi S; Rouhollahi E; Karimian H; Fadaeinasab M; Firoozinia M; Ameen Abdulla M; Abdul Kadir H
    PLoS One; 2015; 10(4):e0122288. PubMed ID: 25860620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.
    Horton NC; Mathew SO; Mathew PA
    PLoS One; 2013; 8(3):e59552. PubMed ID: 23527218
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth.
    Tan Z; Wortman M; Dillehay KL; Seibel WL; Evelyn CR; Smith SJ; Malkas LH; Zheng Y; Lu S; Dong Z
    Mol Pharmacol; 2012 Jun; 81(6):811-9. PubMed ID: 22399488
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.
    Rosental B; Brusilovsky M; Hadad U; Oz D; Appel MY; Afergan F; Yossef R; Rosenberg LA; Aharoni A; Cerwenka A; Campbell KS; Braiman A; Porgador A
    J Immunol; 2011 Dec; 187(11):5693-702. PubMed ID: 22021614
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Renal carcinogenesis after uninephrectomy.
    Sui Y; Zhao HL; Lee HM; Guan J; He L; Lai FM; Tong PC; Chan JC
    Transl Oncol; 2009 Dec; 2(4):258-63. PubMed ID: 19956387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.